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Abstract: Biodegradable polymers can be applied to a variety of implants for controlled and 
local drug delivery. The aim of this study is to develop a biodegradable and nanoporous poly-
meric platform for a wide spectrum of drug-eluting implants with special focus on stent-coating 
applications. It was synthesized by poly(DL-lactide-co-glycolide) (PLGA 65:35, PLGA 75:25) 
and polycaprolactone (PCL) in a multilayer configuration by means of a spin-coating technique. 
The antiplatelet drug dipyridamole was loaded into the surface nanopores of the platform. Surface 
characterization was made by atomic force microscopy (AFM) and spectroscopic ellipsometry 
(SE). Platelet adhesion and drug-release kinetic studies were then carried out. The study revealed 
that the multilayer films are highly nanoporous, whereas the single layers of PLGA are atomically 
smooth and spherulites are formed in PCL. Their nanoporosity (pore diameter, depth, density, 
surface roughness) can be tailored by tuning the growth parameters (eg, spinning speed, polymer 
concentration), essential for drug-delivery performance. The origin of pore formation may be 
attributed to the phase separation of polymer blends via the spinodal decomposition mechanism. 
SE studies revealed the structural characteristics, film thickness, and optical properties even of 
the single layers in the triple-layer construct, providing substantial information for drug loading 
and complement AFM findings. Platelet adhesion studies showed that the dipyridamole-loaded 
coatings inhibit platelet aggregation that is a prerequisite for clotting. Finally, the films exhibited 
sustained release profiles of dipyridamole over 70 days. These results indicate that the current 
multilayer phase therapeutic approach constitutes an effective drug-delivery platform for drug-
eluting implants and especially for cardiovascular stent applications.
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One of the fields that has benefited from nanomedicine is the design of new 
 drug-delivery and -release systems. These novel systems can be combined with 
state-of-the-art implant technology and, in turn, give birth to drug-eluting implants 
that release therapeutic agents at the site of implantation. One of the most promising 
categories of drug-eluting coatings is considered to be nanoporous platforms with pore 
sizes less than 0.1 μm. Porosity of such low dimensions contributes to the material’s 
high active surface and drug loading, leading to desirable drug release profiles for 
each medical application.1,2
A wide range of different materials and fabrication methods have been used to 
manufacture nanoporous coatings.3 Biocompatible metals and their alloys, such as 
titanium and aluminum, are subjected to a self-ordering porous formation that is 
based on electrochemical processes.4 Polymers and especially block copolymers 
have been widely used to compose nanoporous drug-delivery platforms aimed at 
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clinical applications.5,6 However, their use has been hindered 
because of limited biodegradability and slow degradation 
rates.7 These properties were found to cause undesirable 
side effects, such as hypersensitivity reactions at the site of 
implantation, inflammation, and thrombus formation, which 
can lead to tissue damage and even implant failure.8
In this study, we designed and developed biodegradable 
polymeric matrices in a multilayer configuration character-
ized by a diversity of nanopores for controlled drug loading 
and release. Two classes of poly(DL-lactide-co-glycolide) 
(PLGA 65:35, PLGA 75:25) and polycaprolactone (PCL) 
with different degradation rates constitute the nanolayers 
of the platform, and they were deposited by spin  coating. 
Although this technique has been widely used for the 
deposition of thin films for various applications,9,10 to 
the best of our knowledge this is the first time that it 
has been used for the synthesis of drug-eluting applica-
tions. In particular, novel nanoporous materials with a 
variety of nanopore characteristics (depth, density, and 
diameter) were manufactured to serve as drug reservoirs 
with multiplex loading capacities. The major goals in 
designing drug-delivery systems are to control nanopore 
size, surface properties, and release of pharmacologically 
active agents in order to achieve the site-specific action of 
the drug at the nanoporosity therapeutically optimal rate 
and dose regimen. The control of the nanoporosity of the 
engineered nanomaterials was achieved by the implemen-
tation of highly sensitive techniques, such as atomic force 
microscopy (AFM) and spectroscopic ellipsometry (SE) in 
correlation with variations in deposition parameters.
These multilayer polymeric nanocoatings may serve as a 
drug-eluting platform for a wide spectrum of implants (eg, 
orthopedic, cardiovascular, retinal etc). The design of the 
platform and the selection of polymers and drugs should be 
made in line with the specific medical application. In this 
study, the platform was designed for stent-coating needs.
Several drug candidates, such as immune-suppressive 
agents, anti-inflammatory, and cellular proliferation inhibi-
tors, have been employed for stent coating and evaluated in 
clinical trials. Sirolimus-eluting (Cypher®; Cordis, Miami 
Lakes, FL) and paclitaxel-eluting (Taxus®; Boston Scientific, 
Natick, MA) stents have been extensively used for coronary 
angioplasty.11,12
In our study, dipyridamole (DPM), an antiplatelet drug 
known to inhibit clotting,13 was encapsulated into the external 
layer of the polymeric matrix and the release of the drug was 
monitored over time. We used platelet adhesion studies to 
assess their antithrombogenic effect.
Methods
Materials
Dipyridamole was obtained from Sigma-Aldrich (Athens, 
Greece). NaCl, KCl, KH
2
PO
4
, and Na
2
HPO
4
 were obtained 
from Merck (Darmstadt, Germany). PLGA with different 
lactide:glycolide contents (65:35 with average molecular 
weight [M
w
] = 40,000–75,000 and 75:25 with average 
M
w
 = 66,000–107,000) and PCL (with average M
w
 = 48,000–
90,000) were purchased from Sigma-Aldrich. All solutions 
were prepared with deionized water.
Fabrication of multilayer films
The samples were fabricated by spin coating onto silicon (Si) 
and stainless steel substrates inside a nitrogen-filled  glovebox. 
For the fabrication of polymeric single layers, a solution of 
the corresponding polymer was prepared with a total con-
centration of 10 mg mL−1 in chloroform. The solution was 
spin coated under various experimental conditions ( rotation 
speed = 3–95 × g and spinning time = 18–30 seconds). The 
substrates were cleaned prior to spin coating with isopropanol 
and methanol and blow dried using N
2
 flow. Each layer was 
left overnight to slow dry any residual solvent left before the 
deposition of the next polymeric layer.
Drug-loading studies
A solution of drug (PLGA [65:35] 1:3, weight [w]/w) was 
prepared with a total concentration of 13.3 mg mL−1 in 
chloroform. The initially added amount of the drug was 
1.0 mg. The amount of the drug remaining in the film after 
the spin-coating method was determined by washing the 
substrate with 3 mL of CHCl
3
 and measuring the free drug 
with a UV-1700 ultraviolet (UV)-visible spectrophotometer 
(Shimadzu, Kyoto, Japan) at 292 nm.
Atomic force microscopy  
for platelet adhesion studies
The polymeric layers were imaged by an AFM Solver 
P-47H (NT-MDT, Moscow, Russia) scanning probe micro-
scope at ambient environmental conditions. For platelet 
adhesion studies, human platelet-rich plasma (PRP) was 
prepared after the centrifugation of whole blood drawn 
by venopuncture (kept in tubes with 3.8% citrate acid) 
from healthy donors at 4 × g for 7–10 minutes at room 
temperature. The polymeric films were cleaned by N
2
 flow 
and incubated in PRP at room temperature. AFM was then 
applied for platelet visualization onto the drug-free triple lay-
ers (PLGA [65:35]–PLGA [75:25]–PCL) and DPM-loaded 
ones (PLGA [65:35] + DPM–PLGA [75:25]–PCL) at 1- and 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
5328
Karagkiozaki et al
International Journal of Nanomedicine 2012:7
2-hour intervals in the tapping mode for better image acqui-
sition and avoidance of platelet damage.14 The quantities 
that were used for the evaluation of surface roughness of 
the multilayer films before and during platelet adhesion 
were peak-to-valley (R
y
) distance and root-mean-square 
roughness (R
q
). Ten areas of the samples were chosen 
at random to obtain statistical averages of the R
q
 and R
y
 
parameters by Student’s t-test.
Spectroscopic ellipsometry studies
The optical properties of the PLGA and PCL films were 
studied with the SE technique using a phase-modulated 
spectroscopic ellipsometer (by Horiba/Jobin-Yvon), 
covering the extended spectral range from near-infrared 
to far UV (1.5–6.5 eV). It has already been established 
that SE is a suitable technique for measuring the optical 
constants of the materials.15 However, few data have been 
reported on the optical characterization of polymeric thin 
films using SE. Ellipsometry measures changes in the 
reflectance and phase difference between the parallel (R
p
) 
and perpendicular (R
s
) components of a polarized light 
beam upon reflection from a material surface. Using the 
following equation:
 
tan .Ψ ∆( ) =ei R
R
p
s  
(1)
The intensity ratio of R
p
 and R
s
 can be related to the 
amplitude ratio (Ψ) and the phase difference (∆) between the 
two components of polarized light.15 Because ellipsometry 
measures the ratio of two values originating from the same 
signal, the data collected are accurate and  reproducible. 
Moreover, the changes in polarization measured by ellip-
sometry are extremely sensitive to thickness (down to 
monolayer level), microstructure, and optical properties of 
the film under study.
In vitro drug release studies
The multilayer polymeric films (n = 7 indicates the number 
of substrates coated with the polymeric films) loaded with 
dipyridamole were immersed in phosphate buffered saline 
(PBS) at 37°C for 70 days in order to determine the drug-
release kinetics. The release studies were conducted in 
24-well cell culture clusters (Costar; Corning, Manassas, VA) 
containing 1.0 mL of PBS (pH 7.4). Sodium azide (0.05% 
w/volume) was added to the medium in order to prevent 
bacterial growth. The medium was removed (completely) at 
each sampling time (2, 6, and 12 hours and 1, 2, 3, 5, 7, 14, 
21, 28, 35, 49, 56, and 70 days) assayed with UV at 292 nm 
and fresh medium introduced.
Results
Surface nanotopography and structural 
properties of single- and multilayer-
polymeric films
The surface morphology of the polymeric films was inves-
tigated by AFM. A series of single-layer polymeric films 
was first fabricated. Figure 1A illustrates the topography 
image of a single-layer film made of PLGA (75:25), while 
the topography image of a single-layer film made of PCL is 
depicted in Figure 1B. The AFM images revealed that the 
PLGA films were atomically smooth with a surface roughness 
of  0.2 nm under variable experimental conditions. In contrast 
to the PLGA films, the PCL films (Figure 1B) were less 
smooth with a surface roughness of ca. 5.5 nm. The surface 
topography demonstrated the formation of spherulites with 
various sizes (5–40 nm) as an outcome of the crystalliza-
tion process that takes places after thin-film deposition. In 
Figure 1E, the corresponding X cross sections of Figure 1B 
and C indicate that the holes between the spherulites of the 
PCL single layers reaches ca. 8 nm and the pore depth in the 
dual layers is ca. 10 nm.
After fabricating single-layer samples, dual-polymeric 
layers made of PLGA (as the outer layer) and PCL (as 
the inner layer) were constructed. Figure 1C presents the 
topography image of a dual-layer polymeric film. In the 
dual-layer polymeric films, the formation of nanopores was 
evident. Characterization of the pores revealed variation in 
diameter (20–170 nm) and in depth (2–17 nm). The pore 
density was estimated between 40 and 70 pores/μm2 under 
different experimental conditions. Triple-layer  polymeric 
films composed of PLGA (65:35; outer layer), PLGA 
(75:25; intermediate layer), and PCL (inner layer) were then 
manufactured. Figure 1D presents the topography image of 
a triple-layer film. Nanopores were observed in the triple 
layers as well. Hence, the AFM data demonstrated the for-
mation of nanopores with smaller diameter (20–150 nm) 
and depth compared to the pores formed onto the surface 
of dual-layer polymeric matrices. The pore density of these 
triple layers was estimated between 20 and 80 pores/μm2. 
The AFM data involving the surface roughness param-
eters and pore characteristics of all layers are presented 
at Table 1.
In an attempt to investigate to what extent the  process 
of pore formation can be controlled, the triple-layer 
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films were fabricated under variable experimental conditions: 
(a) By altering the spinning speed at 24 × g and 53 × g, two 
series of triple-layer films were developed. Figure 2 depicts 
the AFM topography images of triple-layer films, spin coated 
at 24 × g for 30 seconds and at 53 × g for 30 seconds. Both 
samples had a polymer concentration of 10 mg mL−1; (b) by 
variations in polymer  concentration of the outer layer (5 mg 
mL−1 and 10 mg mL−1).  Figure 2 shows the topography 
images of triple-layer films, one with a polymer concentra-
tion of 10 mg mL−1 and the other with a concentration of 
5 mg mL−1. Both samples were spin coated at 24 × g for 
30 seconds. These two parameters were correlated with the 
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Figure 1 AFM topography images of: (A) PLGA single layer that was spin coated at 53 × g for 30 seconds. (B) PCL single layer that was spin coated at  53 × g for 30 seconds. 
(C) Dual layer (PLGA [75:25]–PCL) that was spin coated at 53 × g for 30 seconds. (D) Triple layer (PLGA [65:35]–PLGA [75:25]–PCL) that was spin coated at 53 × g for 
30 seconds. The scan size is 2.5 μm × 2.5 μm. (E) Corresponding X cross sections of Figure 1B and C that reveal the dimensions of the holes between the spherulites of PCL 
single layers and the pore sizes of PLGA–PCL dual layers, respectively.
Abbreviations: PLGA, poly (DL-lactide-co-glycolide); PCL, polycaprolactone.
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surface roughness, pore depth, diameter, and pore density of 
the engineered triple layers (Table 2).
Spectroscopic ellipsometry studies for 
optical characterization of polymeric 
layers
SE was successfully employed for determining the optical 
properties, thickness, and structural characteristics of the 
spin-coated polymeric films, either in the form of single-, 
dual-, or triple-layer structure. The optical model that was 
applied to analyze the measured data consisted of the appro-
priate number of layers for each case. For determining the 
optical properties and the thickness of the films, a standard 
fitting procedure was applied in which the dielectric func-
tion ε(ω) of the polymeric films was described using the 
Tauc–Lorentz (TL) oscillator dispersion equation, where the 
imaginary part of the dielectric function is given by
 
ε ω
ω ω ω
ω ω ω ω
ω ω2
0
2
2
0
2 2 2 2
1
( )
( )
( )
, ,=
−
− +
⋅ >
A C
C
g
g  (2)
where ω is the photon energy, ω
g
 the fundamental band gap 
energy, A the amplitude  of the oscillator, ω
0
 the Lorentz 
resonant energy, C its broadening term, and the real part ε
1
(ω) 
is obtained by the Kramer–Kronig integration.16
The real part of the refractive index (n) and the extinction 
coefficient (k) of the complex refractive index are related to 
the dielectric function by the following equations:16
	 ε
1
 = n2 – k2 (3)
and
	 ε
2
 = 2nk (4)
Figure 3 shows the experimentally measured pseudodi-
electric function ,ε(ω). (curves with symbols) of single 
PLGA 75:25, PCL,  dual-(PLGA [75:25]–PCL) 75:25–PCL 
films, and triple-(PLGA [65:35]–PLGA [75:25]–PCL)  films 
that were spin coated at 53 × g. The ,ε(ω). accounts for 
the effect of film thickness and the substrate in addition to 
the dielectric response of the bulk film, and this is evident 
by the multiple reflections that appear in the spectra. The 
multiplex reflections are expected to be eliminated when 
the penetration depth of light becomes smaller than the 
film thickness. However, in our cases the whole spectra are 
dominated by multiple reflections since the PLGA and PCL 
Table 1 AFM data of the surface characteristics of the drug-free polymeric layers
Rq (nm) Ry (nm) Pore depth 
(nm)
Pore diameter 
(nm)
Pore density 
(pores μm-2)
Single layers
 PLGA 75:25 0.2 ± 0.02 2.1 ± 0.3 – – –
 PCL 5.5 ± 1 55 ± 16 – – –
Dual layers 1.1 ± 0.3 14.2 ± 3 2–17 20–170 40–70
Triple layers 0.3 ± 0.06 7 ± 3 1–7 20–150 20–80
Abbreviations: AFM, atomic force microscopy; PLGA, poly (DL-lactide-co-glycolide); PCL, polycaprolactone; Ry, peak-to-valley distance; Rq, root mean square roughness.
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Figure 2 AFM topography images of the triple layer (PLGA [65:35]–PLGA [75:25]–PCL) fabricated under variable experimental conditions. (A) Polymer concentration 
of 10 mg mL−1, spin coated at 24 ×  g for 30 seconds; (B) polymer concentration of 10 mg mL−1, spin coated at 53 × g for 30 seconds; and (C) polymer concentration of 
5 mg mL−1, spin coated at 24 × g for 30 seconds. 
Note: The scan size is 10 μm × 10 μm.
Abbreviations: PLGA, poly (DL-lactide-co-glycolide); PCL, polycaprolactone.
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Figure 3 The experimental pseudodielectric functions (symbols) and the corresponding simulated ones (solid lines) determined by the use of best-fit results or the single-layer 
polymeric films: (A) PLGA 75:25–c-Si, (B) PCL–c-Si, (C) the dual-layer PLGA (PLGA [75:25]–PCL-c-Si), and (D) the triple-layer (PLGA [65:35]–PLGA [75:25]–PCL-c-Si).
Note: The insets in the figures show the geometrical model, which was applied in each case, and the respective thicknesses of the polymeric films derived by the fitting 
analysis.
Abbreviations: PLGA, poly (DL-lactide-co-glycolide); PCL, polycaprolactone; Si, silicon.
Table 2 AFM data of triple layers (PLGA [65:35]–PLGA [75:25]–PCL)  fabricated under variable experimental conditions
Polymer concentration  
(mg mL-1)
Spinning speed  
(rpm)
Pore depth  
(nm)
Pore diameter  
(nm)
Pore density  
(pores per μm2)
Rq (nm)
10 24 × g 1–7 20–120 25 0.4
10 53 × g 1–6 20–150 20 0.5
5 24 × g 3–8 20–310 43 1.8
Abbreviations: AFM, atomic force microscopy; PLGA, poly (DL-lactide-co-glycolide); PCL, polycaprolactone; Rq, root mean square roughness.
start to absorb at energies above the upper experimental 
energy limit. In Figure 3, solid lines at the respective plots 
correspond to the simulated spectra derived by the applied 
fitting procedure. By this procedure, the films’ thicknesses, 
the bulk dielectric functions, and the refractive indices of the 
produced PLGA and PCL films were calculated. In Figure 4 
the corresponding real part of the complex refractive index n, 
referred to the bulk materials, has been plotted; we omitted 
the contribution of the thickness and the substrate, and the 
best-fit parameters of the TL oscillator model were used to 
reproduce the dielectric function or refractive index of the 
PLGA and PCL materials.
The AFM data obtained for the single-layer films were in 
agreement with the SE data analysis since for the case of  PLGA 
films there was no need to introduce an additional layer in the 
applied geometrical model (air/film/substrate) for the analysis 
in order to take into account the surface roughness. Indeed, the 
PLGA films were found to be atomically smooth.
In contrast, better fitting analysis was established by 
the introduction of a four-phase model (air/surface layer/
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film/substrate) for the case of PCL films (see also inset in 
Figure 3B). With this model analysis, the surface rough-
ness was represented by a top layer that is composed of 
polymeric material (PCL) and air (voids) with an equal 
percentage of 50%. The calculated effective thicknesses of 
these rough layers for the variable PCL films varied from 
2.5 to 8.6 nm.
The formation of nanopores or voids in the dual- (PLGA 
75:25–PCL) and triple-layer films (PLGA 65:25–PLGA 
75:25–PCL) was also verified by the SE studies. More spe-
cifically, from Figure 4 where the bulk refractive index n has 
been plotted versus photon energy, nanopores formation is 
evident from the reduction of the n values in both PLGA and 
PCL films that consist of dual- and triple-layer polymeric 
film compared to those derived for the single-layer films. The 
decrease in n values may be due to the reduction in the density 
of the material and partially due to the surface and interface 
roughness in PCL and PCL–PLGA layers. Moreover, it is 
noticeable that a more drastic reduction in the n values was 
deduced for the PCL films compared to the PLGA. Therefore, 
we can interpret the SE results with nanopore formation in 
the dual- and triple-layer films.
Platelet adhesion studies onto drug-free 
and drug-loaded triple-polymeric layers
In order to perform platelet adhesion studies, drug-free and 
dipyridamole-loaded triple-layer films (PLGA 65:35–PLGA 
75:25–PCL) were synthesized (Figures 1D and 5A, 
respectively). The DPM-loaded triple layer was characterized 
by a slight increase of surface roughness (R
y
 12 nm and R
q
 
1.4 nm) compared to the drug-free one (R
y
 9.5 nm and R
q
 
0.3 nm) (Table 3). As it is essential to monitor the polymer 
degradation of this triple layer when it comes in contact 
with plasma, the DPM-loaded triple layer was placed in 
PBS solution for 15 minutes (Figure 5B). Interestingly, the 
PLGA polymer starts to degrade even at this initial stage 
causing the initiation of drug release and an increase of pores 
diameter and  surface roughness of the material (R
y
: 310nm 
and R
q
: 64nm of the sample in plasma versus R
y
: 12nm 
and R
q
: 1.4nm in ambient). The topography images of both 
drug-free and drug-loaded films after 1 hour and 2 hours of 
platelet adhesion are shown in Figure 6.
Platelets after their contact with biomaterials are activated 
and undergo the following morphological changes: (i) their 
shape gets flatter, (ii) the granules are gathered into the center 
of the cell, forming the pseudo nucleus (egg-like type), and 
(iii) broad pseudopodia (filopods) extend, which are essential 
for platelets spreading onto surfaces and for aggregation.17 
These structural alterations of platelets during activation can 
be imaged by AFM in detail, as described in previous studies.18 
The cells then release biochemical compounds (eg, serotonin, 
thromboglobulin, platelet factor IV, thromboxane) for further 
activation and aggregation.17
In Figure 6A, the platelets after 1 hour of adhesion 
onto the drug-free sample were found at different stages of 
activation: (a) egg-like type platelets, less activated, denoted 
by circles; (b) more activated platelets with pseudonucleus 
and  pseudopodia, as presented by the blue squares; and (c) 
platelet aggregation (height ca. 411 nm) within the red squares, 
a stage that precedes clot formation. In Figure 6B, the AFM 
topography image of platelets after 2 hours of adhesion onto 
the drug-free sample is depicted. It can be easily noticed that 
the encircled platelets form aggregations reaching the height 
of ca. 565 nm. In Figure 6C, the platelets onto the drug-loaded 
samples after 1 hour of adhesion develop pseudopodia and 
form clusters with a height of ca. 245 nm, and after 2 hours 
the height of platelet clusters reaches approximately 245 nm 
(as measured by the corresponding cross section, inset of 
Figure 6D).
The surface roughness (R
q
 and R
y
) parameters after 1 hour 
and 2 hours of platelet adhesion on the drug-free sample and 
DPM-loaded triple-layer films are listed in Table 3.
Drug release kinetics
The amount of drug remaining in the substrate after the spin-
ning process was estimated to be 2.82% ± 0.40% of the initial 
amount. The cumulative release profiles from the triple-layer 
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PCL from the triple-layer film.
Abbreviations: SE, spectroscopic ellipsometry; PLGA, poly (DL-lactide-co-glycolide); 
PCL, polycaprolactone.
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sample are depicted in Figure 7. The release profiles can be 
divided into four main stages: burst release during the first 
5 hours (inset to Figure 7); an exponential release rate dur-
ing the first week; approximately constant release rate dur-
ing weeks 2–7; and finally an increased release after week 
7 to week 10. This indicates that the assembled therapeutic 
multilayer was slowly disassembled with a release of DPM 
in a controlled manner, possibly along with a change in the 
multilayer thickness. It is likely that the degradation of the 
hydrophobic core (PLGA) induces the formation of particles, 
and subsequent partitioning of DPM from the hydrophobic 
core to an aqueous medium could be mainly responsible for 
the resulting DPM release patterns.
Discussion
There are clinical needs for the development of  biomaterials 
for implants with diverse functionalities, such as controllable 
and multiplex drug release from their surface, in order 
to serve different goals in the f ight against diseases. 
For example, in cardiovascular stents the antiplatelet drugs for 
avoidance of thrombosis and the antiproliferative drugs for 
inhibition of smooth muscle cells proliferation and restenosis 
should be eluted at different time intervals and in a control-
lable manner. Furthermore, few studies have shown that the 
nonbiodegradable polymeric drug reservoirs that comprise 
the drug-eluting stents (DES) may cause a chronic inflam-
mation and hypersensitivity of the vessel wall.20,21
For that reason, in our study biodegradable polymers 
were selected for manufacturing the drug-delivery platform. 
Both PLGA and PCL, which are fully biodegradable due 
to hydrolysis of their ester bonds during their degradation, 
were used to form the layers of the platform. Targeting their 
potential application as coatings for DES, the polymers were 
deposited with a specific order that is in accordance with 
their degradation rates. In order to achieve a sustained drug 
elution profile, we designed the construct in a way that the 
outer polymeric layer will have the fastest degradation rate, 
while the inner polymeric layer will need much more time to 
degrade. The PCL was selected to serve the inner layer since 
its degradation rate is much slower (greater than 24 months) 
compared to that of PLGA (around 3–6 months).22
As regards the two PLGAs with lactide:glycolide ratios 
of 65:35 and 75:25, it has been shown that the time required 
for degradation of PLGA is related to the monomers’ ratio 
used in production – the higher the content of glycolide 
units, the lower the time required for degradation.23 As a 
result, the intermediate layer made of PLGA 75:25 requires 
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Figure 5 AFM topography images of the triple layer (PLGA [65:35]–PLGA [75:25]–PCL) loaded with dipyridamole: (A) as fabricated by spin coating at 53 × g for 30 seconds 
and (B) after its degradation in PBS solution for 15 minutes. 
Note: The scan size is 2.5 μm × 2.5 μm. 
Abbreviations: AFM, atomic force microscopy; PLGA, poly (DL-lactide-co-glycolide); PCL, polycaprolactone; PBS, phosphate buffered saline
Table 3 AFM data of platelet adhesion onto drug-free and drug-
loaded triple layer (PLGA [65:35]–PLGA [75:25]–PCL)
Before  
platelet  
adhesion
After 1 hour  
platelet  
adhesion
After 2 hours 
platelet 
adhesion
Rq (nm)
 Drug- free 0.3 52.7 58.2
 Drug-loaded 1.4 33.7 29.7
Ry (nm)
 Drug- free 9.5 411.3 565.5
 Drug-loaded 12.5 246.3 245.4
Abbreviations: AFM, atomic force microscopy; PLGA, poly (DL-lactide-co-
glycolide); PCL, polycaprolactone; Ry, peak-to-valley distance; Rq, root mean square 
roughness.
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Figure 7 The dipyridamole cumulative release profiles from the three layer samples.
Note: The inset graph depicts the burst effect that occurs during the first 5 hours.
more time to degrade compared to the outer layer made of 
PLGA 65:35.
In a fundamental drug-release study of biomaterials, 
an uncontrolled drug release occurred when drug adhered 
to the outer surface rather than being deposited within the 
pores.24 There are difficulties with control of loading and 
release of drug from nanometer-sized pores, which is a sig-
nificant challenge due to their small size. Thus, in this study 
we describe an experimental procedure for manufacturing 
multilayer polymeric thin films with tailored nanoporosity for 
drug loading by the implementation of spin coating. It was 
noticeable by the data provided by the surface characteriza-
tion techniques AFM and SE that the PLGA–PCL multilayers 
were highly nanoporous in contrast to the smooth PLGA and 
spherulite-characterized PCL single layers.
The origin of pore formation may be attributed to a 
demixing process, which generally involves the spontane-
ous phase separation of polymer blend occurring under 
the specific conditions of spin coating. Similar holes or 
pores have been reported with a polymer blend phase 
separating via a spinodal decomposition mechanism.25 
At the initial stages of spin coating, the upper part of the 
substrate film was dissolved, forming a blend solution 
since chloroform is a common solvent for the selected 
polymers. This hypothesis was verified by the SE data 
showing that the thickness of the substrate f ilm was 
reduced after the deposition of the subsequent film (as 
depicted in Figure 3C and D).
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of their functionality as well as for the prediction of their 
effectiveness.
In this work we show successful implementation of SE 
for determining the  thicknesses, nanoporosity and the opti-
cal constants of the spin-coated polymeric films. In regards 
to thickness measurements, the SE data revealed (Figure 3C 
and D) that the thickness of the substrate film  was reduced 
after the deposition of the subsequent film due to a spinodal 
decomposition mechanism. 
Dipyridamole was selected for loading within the 
nanopores of the polymeric multilayers to examine their 
antiplatelet effect in order to be used as potential coatings 
for cardiovascular implants. The ultimate goal was to inhibit 
thrombus formation, which may lead to implant failure and 
patient complications. The DPM burst effect and release pro-
file during the first week was typical of diffusion-controlled 
systems. The third and fourth phase of the constant release 
rate presumably involved degradation of PLGA combined 
with diffusion of the remaining drug that was more firmly 
attached to polymer.
As polymer degradation is an important factor that 
determines drug elution, the AFM enables us to image the 
degraded DPM-loaded triple-polymeric layer after placing 
it in PBS solution for 15 minutes. At this initial stage, an 
increase in surface roughness of the drug-loaded layer was 
observed due to the degradation of PLGA, the formation of 
particles occurred, and there was resultant partitioning of the 
drug from PLGA, causing drug release.
Our previous studies have shown that AFM is a useful tool 
for imaging platelets in real time, with high precision and 
without destroying sensitive cells.27,28 The AFM images of 
platelets onto drug-free, triple-layer, polymeric films showed 
that the platelets are highly activated, forming pseudopodia 
and aggregates. From the AFM data presented in Table 3, it 
can be deduced that there was a time-dependent increase of 
R
q
 and R
y
 parameters, indicative of platelet aggregation. Our 
previous studies showed that the process of platelet adhesion 
onto nanomaterials that are atomically smooth or have low 
nanoroughness is time-dependent, resulting in an increase in 
R
y
 due to platelet aggregation.28,29
In contrast, in the case of the DPM-loaded triple-layer 
configuration of the biodegradable polymers, after 1 hour of 
platelet adhesion, although the cells develop pseudopodia and 
aggregations, the height is lower and remains at the same level 
after 2 hours. These findings provide evidence that dipyrida-
mole loaded into the outer layer inhibits the platelet tendency 
to form high clusters, which are a prestage of thrombus. More-
over, although the triple-layer drug-loaded films are rougher 
In addition, Affrossman et al26 reported that morphology 
evolution is strongly depended on the polymer blend ratio 
and the film thickness. If the weight content of one compo-
nent in a polymer blend is much higher (about 90%) than 
the other component, then small holes are observed. When 
this fraction decreases to about 70%, the diameter of the 
holes increases and the holes start to coalesce. An analo-
gous behavior is observed in our case comparing Figure 2A 
and C; in Figure 2A the concentration of the added PLGA 
(65:35) solution is 10 mg mL−1, while in Figure 2C the 
concentration is 5 mg mL−1. Since the amount of the added 
solution is the same in both cases, the reduction in the film 
thickness and the percentage analogy of the two types of 
PLGA in the latter case explains its characteristic morphol-
ogy (Figure 2C).
The pore distribution in the nanoporous biomaterials 
is a key factor for determination of drug release kinetics 
and directional control. By varying the size (ie, diameter, 
volume) and number of the porous reservoirs, a range of 
therapeutic agent loading levels can be achieved.25 In the 
case of DES where the drug targets different sites of the 
vessel, it is  necessary to control the porosity of the stent 
nanocoatings for directional and tailored drug loading 
and resultant release. In this study we found that by tun-
ing the spin-coating parameters, the pore distribution and 
dimensions, interconnectivity, and density of the materials 
can be controlled. The AFM images demonstrated that by 
increasing the spinning speed, the pore diameter and surface 
roughness were increased, whereas the pore density was 
decreased. The pore depth was not found to be affected by 
this parameter, as shown in Table 2. Moreover, the decrease 
in the polymer concentration of the outer layer of PLGA 
(65:35), keeping the rotation speed and spinning time con-
stant, resulted in an increase in pore diameter, pore density, 
and surface roughness of the engineered biomaterials (as 
presented at Table 3).
In controlled polymeric drug-delivery systems, the drug-
delivery rates are mainly determined by the dynamics of 
polymer degradation, which is strongly related to polymer 
structure, morphology, and properties. All these can be cor-
related to the optical properties of the polymeric films. The 
study of the optical properties and the consequent creation 
of a database containing specific optical constants of the 
candidate polymeric films for such systems can provide a 
powerful tool for a nondestructive and creditable methodol-
ogy to evaluate their performance. Hence, one can consider 
that the complete elucidation of the optical response of 
the engineered systems is essential for the achievement 
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compared to the drug-free films (R
y
 12.5 nm versus 9.5 nm and 
R
q
 1.4 nm versus 0.3 nm, respectively) after 1 hour of platelet 
adhesion there is a decrease in surface roughness (as depicted 
by the decrease in R
y
 and R
q
 values). This flattening of the 
surface biomaterials due to platelet adhesion is a phenomenon 
that shows how platelets behave toward nanomaterials with 
grooves, pores, and other morphologic irregularities.
Conclusion
In this study, a multilayer and biodegradable polymeric 
platform with diverse nanopores for drug-eluting implants 
was successfully developed. The design of the multilayer 
drug-eluting coatings was based on polymer degradation rates 
and properties in order to achieve a long-term and controlled 
drug elution profile; the spin-coating technique was imple-
mented for this purpose. The spontaneous phase separation 
of polymer blends during spin-coating conditions leads to 
the creation of nanopores via the spinodal decomposition 
mechanism. The formation of nanopores onto the biomaterial 
surface with tailored characteristics (pore diameter, depth, 
density, surface roughness) was achieved by tuning the 
growth parameters.
The complementary AFM and SE studies for determina-
tion of structural characteristics, film thickness, and optical 
properties provide essential information for drug-loading 
capacities. A case study of dipyridamole loading within 
the nanopores and platelet studies for evaluation of their 
antiplatelet effect was carried out. It was found that the 
dipyridamole-loaded coatings inhibit the platelets tendency 
to form high aggregations.
 In-parallel, drug release kinetics studies shown the 
release profiles of DPM that  indicate that the biodegradable 
multilayer was slowly degraded with releasing DPM in a 
controlled manner. By fine tuning the dipyridamole release 
amount in a desired period, it would be possible to prevent 
thrombosis and recreate physiologically normal arterial 
conditions after DPM release.
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